The healthcare landscape shifted significantly in May 2026 when the FDA granted approval to the first biosimilar versions of golimumab, marking a new chapter for millions of patients. This regulatory milestone introduced Immgolis and Immgolis Intri as alternatives to the established reference
Maryland has officially entered a new era of medical care where the state’s comprehensive legislative package, designed to tackle rising costs and access gaps, is finally seeing its full-scale implementation across every county. For years, residents struggled with the ballooning expenses of chronic
Residents in Vermont's most isolated communities often find themselves hours away from the nearest hospital, forcing many to delay essential medical attention until minor symptoms escalate into life-threatening emergencies. This geographic isolation has long defined the state's healthcare
The persistent fragmentation of the American medical infrastructure has reached a critical juncture where technological advancement often outpaces the system's ability to provide compassionate, goal-aligned support for those with chronic illnesses. Despite possessing sophisticated diagnostic
The legislative battle over prescription drug pricing has reached a fever pitch in the Midwest as the primary trade group for pharmacy benefit managers has officially filed a federal lawsuit against the state of Illinois. This legal challenge targets the newly enacted Healthcare Protection Act, a
The rapid evolution of autonomous agents has fundamentally altered the landscape of modern medicine, moving beyond mere predictive modeling to systems that can actively execute complex clinical workflows without constant manual oversight from overburdened staff members. While earlier versions of
